Results 11 to 20 of about 1,385 (194)

IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE (IMCD) AS A MANIFESTATION OF POST-COVID-19 INFLAMMATORY SYNDROME [PDF]

Chest, 2022
YAN, CHRIS, HALLIGAN, KYLE
europepmc   +3 more sources

P911: SYMPTOM BURDEN AND ITS IMPACT ON DAILY LIFE AMONG PATIENTS WITH IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE (IMCD) – FINDINGS FROM AN INTERNATIONAL IMCD PATIENT SURVEY [PDF]

Hemasphere, 2022
Background: Background: Idiopathic Multicentric Castleman disease (iMCD) is a rare lymphoproliferative disorder driven by proinflammatory hypercytokinemia.
Shupo F, Mason N, Jones E, Wayi-Wayi G, Repasky M, Franklin M, Brazier J, Zibelnik N, Mukherjee S.   +8 more
europepmc   +4 more sources

Clinical Presentation, Treatment, and Outcomes of 28 Patients With Castleman Disease: A Retrospective Analysis of an Italian Cohort [PDF]

eJHaem
Background Castleman disease (CD) encompasses a range of heterogeneous non‐clonal lymphoproliferative disorders, including unicentric (UCD), and multicentric (MCD) forms.
Caterina Cristinelli, Michele Merli, Marco Lucioni, Manuel Gotti, Roberta Sciarra, Sara Rattotti, Federico Carpi, Gianmarco Favrin, Benedetta Bianchi, Giuseppe Neri, Marta Coscia, Marcello Gambacorta, Francesco Passamonti, Marco Paulli, Luca Arcaini   +14 more
doaj   +3 more sources

Distinct interleukin-6 production in IPL and TAFRO subtypes of idiopathic multicentric Castleman disease [PDF]

Haematologica
Idiopathic multicentric Castleman disease (iMCD) is a rare lymphoproliferative disorder characterized by systemic inflammation and lymphadenopathy.
Asami Nishikori, Midori Filiz Nishimura, Yoshito Nishimura, Rio Yamada, Tomoka Haratake, Daisuke Ennishi, Ryota Chijimatsu, Toshihiro Ito, Tomohiro Koga, Sayaka Ochi, Yuri Kawahara, Himawari Ueta, Yudai Takeda, Michael V. Gonzalez, David C. Fajgenbaum, Frits van Rhee, Shuji Momose, Yasuharu Sato   +17 more
doaj   +4 more sources

TAFRO Syndrome Without Pathology Supporting Castleman Disease: To Be Treated as Idiopathic Multicentric Castleman Disease-TAFRO or a Distinct Disease Entity? [PDF]

Turkish Journal of Hematology
Objective: TAFRO syndrome, entailing thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly, was previously considered a subtype of idiopathic multicentric Castleman disease (iMCD-TAFRO), with the diagnosis requiring pathology supporting
Siyuan Li, Yuhan Gao, Yue Dang, Lu Zhang, Jian Li   +4 more
doaj   +3 more sources

The Evolution and Recent Advances in Diagnostic Criteria for Idiopathic Multicentric Castleman Disease. [PDF]

Am J Hematol
Idiopathic Multicentric Castleman Disease. ABSTRACT Idiopathic multicentric Castleman disease (iMCD) is a rare cytokine‐driven disorder characterized by systemic inflammation, organ dysfunction, and altered lymph node microscopic architecture. Over the past decade, diagnostic criteria have evolved significantly, integrating clinical, histopathological,
Alnoor F, Spies NC, Kumar J, Samghabadi P, Silva O, Luo MX, Chisholm KM, Zhang J, Rangel A, Ng D, Li P, Ohgami RS.   +11 more
europepmc   +3 more sources

PS1403 IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE (IMCD) IN EUROPE: A HETEROGENEOUS DISEASE TREATED WITH A VARIETY OF AGENTS

HemaSphere, 2019
Background:Idiopathic multicentric Castleman disease (iMCD) is a rare and heterogeneous plasmacytic lymphoproliferative disorder that involves multiple regions of lymphadenopathy and cytokine‐driven systemic inflammatory symptoms. Many patients experience life‐threatening multi‐organ failure.
C. Hoffmann, L. Terriou, P.L. Zinzani, A. Fosså, E. Oksenhendler, M. Streetly, D. Gibson, K. Kanhai, A.G. García, L. Angenendt, S. Ferrero, J.L. Patier, S. Pierson, D. Fajgenbaum   +13 more
openaire   +2 more sources

International Consensus Histopathological Criteria for Subtyping Idiopathic Multicentric Castleman Disease Based on Machine Learning Analysis. [PDF]

Am J Hematol
ABSTRACT Idiopathic multicentric Castleman disease (iMCD) is a rare lymphoproliferative disorder classified into three recognized clinical subtypes—idiopathic plasmacytic lymphadenopathy (IPL), TAFRO, and NOS. Although clinical criteria are available for subtyping, diagnostically challenging cases with overlapping histopathological features highlight ...
Nishimura MF, Haratake T, Nishimura Y, Nishikori A, Sumiyoshi R, Ujiie H, Kawahara Y, Koga T, Ueki M, Laczko D, Oksenhendler E, Fajgenbaum DC, van Rhee F, Kawakami A, Sato Y.   +14 more
europepmc   +3 more sources

Idiopathic Multicentric Castleman Disease With Severe Eosinophilia and Diffuse Centrilobular Nodule-A Rare Case Report. [PDF]

Case Rep Hematol
Rationale Idiopathic multicentric Castleman disease (iMCD), also known as angiofollicular lymph node hyperplasia, is a rare inflammatory lymphoproliferative disease with diverse clinical presentations. We report a rare case of iMCD accompanied by severe eosinophilia and diffuse centrilobular pulmonary nodules, which have rarely been previously ...
Li X, Li S, Zhao T, Xu B, Du X, Song X, Wang Y.   +6 more
europepmc   +3 more sources

Exploring the Clinical Diversity of Castleman Disease and TAFRO Syndrome: A Japanese Multicenter Study on Lymph Node Distribution Patterns [PDF]

American Journal of Hematology, Volume 100, Issue 4, Page 592-605, April 2025.
Nagasaki University (長崎大学)博士(医学)Individuals diagnosed with Castleman disease (CD) and TAFRO syndrome (characterized by thrombocytopenia, anasarca, fever, bone marrow fibrosis, and organomegaly) displays a wide range of clinical symptoms, including ...
大塚, 瑞奈
core   +2 more sources